The Conference is organized by the Ministry of Health’s Pharmacy and Poisons Board and managed by Standout Ventures East Africa.
The Pharmacy and Poisons Board is a key government agency that enforces regulations and laws in the pharmaceutical sector. In recent years, the Board has had to battle cases of malpractices in the industry, with certain incidents reported in the Kenyan media. What has emerged from review and audit done by the board is that there are obvious loopholes in the regulatory framework that may have been exploited by unscrupulous people at the expense of industry best practices and regulatory compliance.
The audit also reveals an obvious need for greater industry cohesion and engagement among peers to ensure regulatory procedures are observed at all levels of practice.
It has also emerged that the board has in the past lacked strong governmental regulatory enforcement mechanisms to weed out illegal business activities in the country. In many instances, the Board has successfully stopped reported cases of malpractices, but it is still overwhelmed by some cases of non-compliances.
However, this has only given the board the impetus to craft all possible strategic tools to combat non-compliance with regulations in the industry. This conference is a great step towards engaging the greater pharmaceutical stakeholder fraternity to help fight compliance vices and to encourage greater enforcement of the regulatory framework.
It emerges that lack of compliance breeds fertile ground for potential risks to the lives of the very people the industry is supposed to serve; the general population. In the absence of compliance, and in the occurrence of wanton contravention of regulation, the general population is placed on a precarious situation of danger from use of substandard medical equipment and treatment therapy.
It is not in doubt that counterfeit drugs and medical supplies have found their way onto our pharmaceutical shelves, sometimes with the collusion of stakeholders – and at other times by the lack of proper screening and verification procedures and processes. Either way, the population will always be at risk if regulatory practices are not enhanced and tightened.
This, perhaps, is one industry whose failures would reverberate beyond boardrooms and the walls of various pharmaceutical premises. If measures are not put in place to safeguard what is released to the market and the general population, the industry itself is at risk of damaged credibility and the heightening of tension in the public. A public that is worried and panicked by the quality of pharmaceutical services in the country could easily create a national crisis.
This conference is a first step to ensuring the entire industry rallies around the need to overcome regulatory challenges together, as stakeholders seek common fronts and solutions through which to streamline regulatory practices in the sector.
This is more than just a conference. It is fresh, innovative and genuinely engages the audience.
Join us to learn how to future proof your compliance programme.